Exeliom Biosciences
www.exeliombio.comAt Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
Read more
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of immune-mediated diseases, with specific focus on inflammatory bowel diseases (IBD), and Crohn’s Disease as a first indication
Read more
Country
City (Headquarters)
Dijon
Industry
Employees
1-10
Founded
2016
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Co - Founder
Email ****** @****.comPhone (***) ****-****Chief Executive Officer and Co - Founder
Email ****** @****.comPhone (***) ****-****Operations Director
Email ****** @****.comPhone (***) ****-****Exeliom Biosciences
Email ****** @****.comPhone (***) ****-****
Technologies
(19)
Reach decision makers at Exeliom Biosciences
Free credits every month!
Exeliom Biosciences FAQ
Dijon, France
Biotechnology Research
